Technical Analysis for HAE - Haemonetics Corporation

Grade Last Price % Change Price Change
grade A 100.07 -1.69% -1.72
HAE closed down 1.69 percent on Friday, May 17, 2019, on 64 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical HAE trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
200 DMA Support Bullish -1.69%
Multiple of Ten Bullish Other -1.69%
Overbought Stochastic Strength -1.69%
200 DMA Support Bullish 0.60%
Calm After Storm Range Contraction 0.60%
Multiple of Ten Bearish Other 0.60%
Overbought Stochastic Strength 0.60%

Older signals for HAE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Haemonetics Corporation engages in the design, development, manufacture, and marketing of automated blood component collection devices and surgical blood salvage devices in the United States and internationally. It provides various plasma products, including PCS brand plasma collection equipment and consumables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma customers to manage their donors, operations, and supply chain; and blood center products comprising multicomponent collection system brand apheresis equipment to collect specific blood components integrated from the donor, automated cell processor brand solution to automate the washing and freezing of red cell components in the lab, and filtration products. The company also offers various hospital products, such as TEG thrombelastograph hemostasis analyzer system that measures a patient's hemostasis or the ability to form and maintain blood clots; Cell Saver system for cardiovascular surgery procedures; OrthoPAT surgical blood salvage system for orthopedic procedures; cardioPAT system to open heart surgeries; and IMPACT Online Web-based software platform that monitors and measures improvements in a hospital's blood management practices, provides hospitals with a view of their blood management metrics, and helps monitor transfusion rates. In addition, it offers SafeTrace Tx and BloodTrack suite of solutions, as well as El Dorado Donor donation and blood unit management systems. The company markets and sells its products to commercial plasma collectors, blood collection groups and independent blood centers, hospitals and hospital service providers, and national health organizations through its direct sales force, as well as independent distributors. Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, Massachusetts.
Medicine Information Technology Medical Specialties Supply Chain Blood Transfusion Medicine Hematology Blood Clots Blood Transfusion Filtration Products Blood Plasma Hemostasis Plasma Products Web Based Software Platform
Is HAE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 117.555
52 Week Low 80.23
Average Volume 490,517
200-Day Moving Average 98.7605
50-Day Moving Average 89.1724
20-Day Moving Average 92.56
10-Day Moving Average 97.801
Average True Range 2.9189
ADX 32.17
+DI 33.6588
-DI 10.3112
Chandelier Exit (Long, 3 ATRs ) 93.6333
Chandelier Exit (Short, 3 ATRs ) 88.9867
Upper Bollinger Band 104.3242
Lower Bollinger Band 80.7958
Percent B (%b) 0.82
BandWidth 25.41962
MACD Line 3.4638
MACD Signal Line 2.5888
MACD Histogram 0.875
Fundamentals Value
Market Cap 5.27 Billion
Num Shares 52.6 Million
EPS 0.08
Price-to-Earnings (P/E) Ratio 1250.88
Price-to-Sales 2.78
Price-to-Book 3.19
PEG Ratio 3.50
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 102.97
Resistance 3 (R3) 103.28 102.62 102.48
Resistance 2 (R2) 102.62 101.89 102.47 102.32
Resistance 1 (R1) 101.35 101.43 101.02 101.04 102.16
Pivot Point 100.69 100.69 100.53 100.54 100.69
Support 1 (S1) 99.42 99.96 99.09 99.11 97.98
Support 2 (S2) 98.76 99.50 98.61 97.82
Support 3 (S3) 97.49 98.76 97.66
Support 4 (S4) 97.18